Table of Contents
Table of Contents
Preface
Intraperitoneal Doxorubicin: Rationale, Pharmacokinetic Studies, and Clinical Results
(Paul H. Sugarbaker, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC, USA)
Preclinical Characterization of the Drug-Delivery Device DCBeads™ for Transarterial Chemoembolization of Doxorubicin and Nemorubicin, a Methoxy-Morpholinyl Derivative
(Francesco Fiore, Olga Valota, Dario Ballinari, Federico Riccardi Sirtori, Maristella Colombo, Michela D’Antò, Cristina Geroni, Paolo Cappella, National Cancer Institute G. Pascale Fondation, Napoli, Italy, and others)
Doxorubicin-Induced Cardiomyopathy
(Xia Wang, Wei Han, Yan Yu, Jinzhou Zhu, Ruiyan Zhang, Laboratory of Regeneromics, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China, and others)
Advanced Therapies of Doxorubicin by Carrier of Drug Delivery System or Combined Food Components
(Yasuyuki Sadzuka, Professor, School of Pharmacy, Iwate Medical University, Iwate, Japan)
Prevention and Management of Cardiotoxicity, Nausea and Vomiting in Doxorubicin-Treated Breast Cancer Patients
(Snezana K. Bjelogrlic, Snezana Susnjar, Nebojsa Ninkovic, Department of Experimental Oncology, National Cancer Research Center, Belgrade, Serbia, and others)
Index
